Baker Ellis Asset Management LLC Novartis Ag Transaction History

Baker Ellis Asset Management LLC

$658 Million
Q4 2024

A detailed history of Baker Ellis Asset Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Baker Ellis Asset Management LLC holds 11,327 shares of NVS stock, worth $1.19 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

11,327

Previous 11,884 4.69%

Holding current value

$1.19 Million

Previous $1.37 Million 19.33%

% of portfolio

0.17%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$96.78 - $117.18 $53,906 - $65,269	-557 Reduced 4.69%	11,327 $1.1 Million
Q3 2024 Oct 15, 2024	SELL	$106.13 - $120.89 $13,266 - $15,111	-125 Reduced 1.04%	11,884 $1.37 Million
Q2 2024 Jul 09, 2024	SELL	$92.57 - $107.37 $14,811 - $17,179	-160 Reduced 1.31%	12,009 $1.28 Million
Q1 2024 Apr 17, 2024	SELL	$95.27 - $108.47 $57,162 - $65,082	-600 Reduced 4.7%	12,169 $1.18 Million
Q3 2023 Oct 24, 2023	SELL	$94.73 - $105.13 $23,682 - $26,282	-250 Reduced 1.92%	12,769 $1.3 Million
Q2 2023 Aug 09, 2023	SELL	$92.52 - $104.91 $9,252 - $10,491	-100 Reduced 0.76%	13,019 $1.31 Million
Q1 2023 May 08, 2023	SELL	$80.03 - $92.81 $40,015 - $46,405	-500 Reduced 3.67%	13,119 $1.21 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $9,292 - $11,379	-123 Reduced 0.9%	13,619 $1.24 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $11,415 - $13,350	-153 Reduced 1.1%	13,742 $1.05 Million
Q2 2022 Jul 22, 2022	BUY	$80.52 - $93.75 $2,093 - $2,437	26 Added 0.19%	13,895 $1.18 Million
Q1 2022 May 04, 2022	BUY	$80.11 - $90.62 $8,011 - $9,062	100 Added 0.73%	13,869 $1.22 Million
Q4 2021 Jan 27, 2022	SELL	$79.7 - $88.13 $20,722 - $22,913	-260 Reduced 1.85%	13,769 $1.2 Million
Q3 2021 Oct 15, 2021	SELL	$81.78 - $95.14 $39,172 - $45,572	-479 Reduced 3.3%	14,029 $1.15 Million
Q2 2021 Aug 10, 2021	SELL	$85.24 - $94.15 $281,377 - $310,789	-3,301 Reduced 18.54%	14,508 $1.32 Million
Q1 2021 Apr 28, 2021	SELL	$83.5 - $98.47 $76,820 - $90,592	-920 Reduced 4.91%	17,809 $1.52 Million
Q4 2020 Feb 04, 2021	SELL	$78.07 - $94.43 $14,052 - $16,997	-180 Reduced 0.95%	18,729 $1.77 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $31,377 - $34,762	-382 Reduced 1.98%	18,909 $1.64 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $36,418 - $40,995	-450 Reduced 2.28%	19,291 $1.69 Million
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $141,340 - $198,020	-2,000 Reduced 9.2%	19,741 $1.63 Million
Q4 2019 Feb 10, 2020	SELL	$84.35 - $95.37 $50,610 - $57,222	-600 Reduced 2.69%	21,741 $2.06 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $200,163 - $220,568	-2,340 Reduced 9.48%	22,341 $1.94 Million
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $73,515 - $90,480	-975 Reduced 3.8%	24,681 $2.25 Million
Q1 2019 May 09, 2019	SELL	$75.32 - $86.15 $62,138 - $71,073	-825 Reduced 3.12%	25,656 $2.47 Million
Q4 2018 Feb 07, 2019	SELL	$73.66 - $82.02 $61,874 - $68,896	-840 Reduced 3.07%	26,481 $2.27 Million
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $699,188 - $808,756	-10,445 Reduced 27.66%	27,321 $2.35 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $365,962 - $413,603	-5,638 Reduced 12.99%	37,766 $2.85 Million
Q1 2018 Apr 19, 2018	SELL	$70.39 - $84.15 $48,569 - $58,063	-690 Reduced 1.56%	43,404 $3.51 Million
Q4 2017 Jan 30, 2018	BUY	$72.33 - $77.64 $36,165 - $38,820	500 Added 1.15%	44,094 $3.7 Million
Q3 2017 Oct 18, 2017	BUY	$74.14 - $77.27 $3.23 Million - $3.37 Million	43,594	43,594 $3.74 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $225B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Ellis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Ellis Asset Management LLC with notifications on news.

Account

Baker Ellis Asset Management LLC Novartis Ag Transaction History